A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsAlberto Zori Comba, A. Schmilovich, Manuel Vilanova et al.|European Journal of Cancer|2001Cited by 37
Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American surveyDana Narváez, Valeria Caceres, Federico Waisberg et al.|Therapeutic Advances in Medical Oncology|2025Cited by 0